FDA Begins Poring Over Mifepristone Safety Data

FDA Begins Poring Over Mifepristone Safety Data The results of the Food and Drug Administration's study of the abortion pill could be used to restrict access by requiring in-person visits for prescribing and dispensing, The Wall Street Journal reported. Plus: Scientists have precisely edited the DNA of human embryos. https://kffhealthnews.org/morning-breakout/reproductive-health-060526/